A double‐blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis : a multicentre trial (Q72009437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A double‐blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis : a multicentre trial (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

multicenter clinical trial

21 July 2024

main subject

1 reference

1 reference

J. Mössner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654895

21 July 2024

A. H. Hölscher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654895

21 July 2024

R. Herz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654895

21 July 2024

A. Schneider

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654895

21 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7654895

21 July 2024

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1995.tb00388.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.1995.tb00388.x

21 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Alimentary Pharmacology & Therapeutics

21 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

321-326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man

22 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.

21 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Lack of influence of pantoprazole on the disposition kinetics of theophylline in man

21 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders

21 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.

21 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

21 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

21 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study

21 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease

21 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.

21 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.

21 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

21 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00388.X

21 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654895%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference